on 25 Jan 2022
Last Applicant/ Owned by
4530 Wisconsin Avenue, NW; 5th Fl.
Washington
DC
20016
Serial Number
90263220 filed on 19th Oct 2020
Registration Number
6625347 registered on 25th Jan 2022
Correspondent Address
Jody H. Drake
Filing Basis
1. use application currently
Disclaimer
NO DATA
Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical, and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval Medical and scientific research, namely, conducting clinical trials for others; Providing medical and scientific Read More
Medical and scientific research, namely, conducting clinical trials for others; Providing medical and scientific research information in the field of clinical trials
30th Nov 1998
30th Nov 1998
Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical, and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval
30th Nov 1998
30th Nov 1998
Providing independent review of clinical trials involving human subjects, namely, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research
30th Nov 1998
30th Nov 1998
No 90263220
No Service Mark
No S24964
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 25th Jan 2022 | REGISTERED-PRINCIPAL REGISTER |
| 09th Nov 2021 | PUBLISHED FOR OPPOSITION |
| 09th Nov 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 20th Oct 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 04th Oct 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 27th Sep 2021 | ASSIGNED TO EXAMINER |
| 20th Sep 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 20th Sep 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 20th Sep 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 19th Mar 2021 | NON-FINAL ACTION E-MAILED |
